Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer

Improved Survival of HER2+Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain

(2016) Keith L. Knutson et al.   CANCER RESEARCH

Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?

(2016) Lucia Festino et al.   DRUGS

The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis

(2016) Pedro N Aguiar et al.   Immunotherapy

Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy

(2016) Nayoung Lee et al.   PATHOLOGY

Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

(2016) P.-L. Chen et al.   Cancer Discovery

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer

(2015) Giovanni Ciriello et al.   CELL

Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial

(2015) L. G. Lum et al.   CLINICAL CANCER RESEARCH

Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers

(2015) Carsten Denkert et al.   JOURNAL OF CLINICAL ONCOLOGY

Robust enumeration of cell subsets from tissue expression profiles

(2015) Aaron M Newman et al.   NATURE METHODS

Immunotherapy for the Treatment of Breast Cancer

(2015) Brenda Ernst et al.   Current Oncology Reports

Trastuzumab upregulates expression of HLA-ABC and T cell costimulatory molecules through engagement of natural killer cells and stimulation of IFNγ secretion

(2015) Bharat K. R. Chaganty et al.   OncoImmunology

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

(2014) R. Salgado et al.   ANNALS OF ONCOLOGY

Adoptive cellular immunotherapy for the treatment of patients with breast cancer: A meta-analysis

(2014) Zheng-Xu Wang et al.   CYTOTHERAPY

Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity

(2014) Denise M. Wolf et al.   PLoS One

Immunotherapeutics for breast cancer

(2013) Carmen Criscitiello et al.   CURRENT OPINION IN ONCOLOGY

Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

(2013) Gabriela Bindea et al.   IMMUNITY

The Prognostic Implications of Macrophages Expressing Proliferating Cell Nuclear Antigen in Breast Cancer Depend on Immune Context

(2013) Michael J. Campbell et al.   PLoS One

Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy

(2013) Sherene Loi   OncoImmunology

Immunomodulation via Chemotherapy and Targeted Therapy: A New Paradigm in Breast Cancer Therapy?

(2012) John Stagg et al.   Breast Care

Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade

(2012) Leisha A Emens   Expert Review of Anticancer Therapy

Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures

(2011) Cheng Fan et al.   BMC Medical Genomics

A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer

(2011) Christos Hatzis   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy

(2011) David G. DeNardo et al.   Cancer Discovery

Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules

(2010) Andrew E Teschendorff et al.   BMC CANCER

Clinical Studies With Anti–CTLA-4 Antibodies in Non-melanoma Indications

(2010) Luana Calabrò et al.   SEMINARS IN ONCOLOGY

Therapeutic Breast Cancer Vaccines

(2009) Nathan M. Shumway et al.   BIODRUGS

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

(2009) Joel S. Parker et al.   JOURNAL OF CLINICAL ONCOLOGY

An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non-Small-Cell Lung Cancer

(2008) P. Roepman et al.   CLINICAL CANCER RESEARCH